PORTAGE BIOTECH INC (PRTG)

Company Profile

Portage Biotech Inc is a VG-based company operating in Biotechnology industry. Portage Biotech Inc. is a clinical-stage immuno-oncology company. The firm is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of four platforms, with lead programs consisting of invariant natural killer T-cell (iNKT) engagers and a suite of treatments targeting the adenosine pathway. Within these four platforms, the Company has nine product candidates, of which five are pre-clinical and four of which are clinical stage. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent targeting the adenosine pathway.

Company Info

PORTAGE BIOTECH INC

Clarence Thomas Building, P.O. Box 4649, Road Town

Tortola ONTARIO VG1110

P: 4167377600

CEO: Ian Walters

Employees: 7

Website: https://portagebiotech.com/